Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

3 Low-Risk Tech Stocks for a Downturn

The market is making some investors nervous, but you don’t have to give up tech altogether to make your portfolio safer.

Why Appian Slumped 15% in 2018

Declining revenue growth rates might not have pleased traders, but it wasn't a bad year for the business.

Why Globus Medical Is Soaring Today

Traders cheer after the company reports pleasing preliminary results for the fourth quarter and shares bullish guidance.

Why TransEnterix Is Soaring Today

Shares jumped after the company provided investors with a slew of positive updates. Here are the key takeaways for investors.

Why Mindbody Is Skyrocketing

Shares soar after the company announces that it's being taken private. Did Christmas come a day early for shareholders?

Is NovoCure a Buy?

Investors in the cancer-focused medical device company have enjoyed strong returns already. Is it too late to hop on board?

3 Top Healthcare Stocks to Buy Right now

Find out why a medical device maker, a gene sequencer, and a drug licensing company have our team of healthcare experts feeling bullish.